Skin and Mucosal Delivery (Focus Group – SMD)
Mafalda Correia, MSc Pharmaceutical Sciences
PhD student
Faculty of Pharmacy, University of Coimbra and The University of Texas at Austin
Coimbra, Portugal
Chronic wounds are a growing clinical challenge, imposing significant physical, emotional, and economic burdens. Infection is a common complication that can lead to biofilm formation, limiting the efficacy of conventional therapies (1). Novel strategies that target biofilms and promote skin regeneration are needed. Usnic acid (UA) is a natural compound with antimicrobial, antibiofilm, anti-inflammatory, and antioxidant properties, but poor water solubility (2). High-cholesterol liposomes offer a promising strategy for improving UA solubility, while increasing bacterial membrane and biofilm affinity and enabling targeted and controlled delivery for chronic wound treatment (3,4).